Read on Twitter
Brazilian 3-arm randomized no-control trial compares hydroxychloroquine / nitazoxanide / ivermectin in early treatment of 585 RT-PCR confirmed COVID outpatients.
Not 1 hospitalization compared to a 16% case average nationally.
Odds ratio: 0.000000. Hmm.
https://www.researchsquare.com/article/rs-98106/v1
Not 1 hospitalization compared to a 16% case average nationally.
Odds ratio: 0.000000. Hmm.
https://www.researchsquare.com/article/rs-98106/v1
A few more points:
> Time to treat 3 days but time from symptom onset
> HCQ / NTZ / IVM equally efficacious. Hmm.
> ca. 80% of patient with vitamin D supplementation
> ca. 50% under spironolactone
> ca. 20% with vitamin C and/or Zinc
Hmm. Amazing...
Too good to be true?
> Time to treat 3 days but time from symptom onset
> HCQ / NTZ / IVM equally efficacious. Hmm.
> ca. 80% of patient with vitamin D supplementation
> ca. 50% under spironolactone
> ca. 20% with vitamin C and/or Zinc
Hmm. Amazing...
Too good to be true?
That trial was not even the primary scientific objective of the authors who pursue an interesting androgenic treatment angle and wanted to select the best of the 3 studied drugs for a further RCT, called AndroCoV.
Have they already solved Covid-19?
https://www.firstwordpharma.com/node/1735447?tsid=17
Have they already solved Covid-19?
https://www.firstwordpharma.com/node/1735447?tsid=17
